The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical factors associated with successful liquid tumor biopsy in men with prostate cancer.
 
Aixia Guo
No Relationships to Disclose
 
Luca Faustino Valle
No Relationships to Disclose
 
Sara Ahmed
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca; PierianDx
 
Kerry G. Rowe
No Relationships to Disclose
 
Colin C. Pritchard
Consulting or Advisory Role - AstraZeneca; Sana Biotechnology
Research Funding - Color Genomics (I)
 
Robert Bruce Montgomery
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Beigene (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst)
 
Isla Garraway
No Relationships to Disclose
 
Nicholas George Nickols
Consulting or Advisory Role - Oncolinea Pharmaceuticals
Research Funding - Bayer; Janssen Scientific Affairs; Progenics; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - I am listed as inventor on patents related to PyIm polyamides that have been licensed by Gene Sciences
 
Kara Noelle Maxwell
No Relationships to Disclose
 
Michael J. Kelley
Research Funding - Bristol-Myers Squibb (Inst); EQRx; Genentech (Inst); Mirati Therapeutics; Novartis (Inst); Regeneron (Inst)
 
Matthew Rettig
Leadership - Aravalent; Survalent
Stock and Other Ownership Interests - Oncovalent Therapeutics; Survalent
Consulting or Advisory Role - Ambrx; Amgen; Clovis Oncology; Inmune Bio; Roivant
Speakers' Bureau - Bayer; Johnson & Johnson
Research Funding - Johnson & Johnson (Inst); Medivation/Astellas (Inst); Novartis (Inst); Progenics
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for novel inhibitors of the N-terminal domain of the AR. There are NO commercial partnerships as of yet.
Travel, Accommodations, Expenses - Johnson & Johnson